Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Index by author

July 01, 1992; Volume 262,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abboa-Offei, B E

    1. You have access
      Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
      A A Seymour, M M Asaad, B E Abboa-Offei, P L Rovnyak, S Fennell and W L Rogers
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 60-70;
  2. Abdel-Rahman, A A

    1. You have access
      Role of aortic baroreceptors in ethanol-induced impairment of baroreflex control of heart rate in conscious rats.
      M M el-Mas and A A Abdel-Rahman
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 157-165;
  3. Abe, S

    1. You have access
      Protective effects of (2E)-3-[5-(2,3-dimethoxy-6-methyl-1,4- benzoquinoyl)]-2-nonyl-2-propenoic acid on endotoxin-mediated hepatitis in mice.
      J Nagakawa, I Hishinuma, K Miyamoto, K Hirota, S Abe, T Yamanaka, K Katayama and I Yamatsu
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 145-150;
  4. Abels, B C

    1. You have access
      Influence of the adenosine receptor antagonist, CGS 15943A, on renal function after reconstruction of chronic renal artery stenosis in the dog.
      B C Abels, J T Callis, R A Branch and R Sabra
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 166-172;
  5. Ableitner, A

    1. You have access
      Neuroanatomical sites mediating the central actions of beta-endorphin as mapped by changes in glucose utilization: involvement of mu opioid receptors.
      A Ableitner and R Schulz
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 415-423;
  6. Ahlenius, S

    1. You have access
      Relationship between brain levels of 3-(3-hydroxyphenyl)-N-n-propylpiperidine HCl enantiomers and effects on locomotor activity in rats.
      J Lundström, J E Lindgren, S Ahlenius and V Hillegaart
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 41-47;
  7. Aloyo, V J

    1. You have access
      Identification and characterization of delta opioid binding sites in the bovine pineal.
      V J Aloyo
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 292-297;
  8. Asaad, M M

    1. You have access
      Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
      A A Seymour, M M Asaad, B E Abboa-Offei, P L Rovnyak, S Fennell and W L Rogers
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 60-70;
  9. Axelson, J E

    1. You have access
      Metabolic effects of ritodrine in the fetal lamb.
      M P van der Weyde, M R Wright, S M Taylor, J E Axelson and D W Rurak
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 48-59;

B

  1. Barry, W H

    1. You have access
      Pharmacological characterization of chick and frog beta adrenergic receptors in primary cultures of myocardial cells.
      J D Port, C C Debellis, J Klein, G A Peeters, W H Barry and M R Bristow
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 217-224;
  2. Basinger, M A

    1. You have access
      Association between increased atrial natriuretic peptide and reduced cisplatin nephrotoxicity in rats.
      P M Ormond, M A Basinger, M M Jones and K R Hande
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 246-251;
  3. Bigelow, G E

    1. You have access
      Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers.
      K L Preston, J T Sullivan, E C Strain and G E Bigelow
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 279-291;
  4. Bloom, J W

    1. You have access
      Chimeric M1/M2 muscarinic receptors: correlation of ligand selectivity and functional coupling with structural modifications.
      J Lai, L Nunan, S L Waite, S W Ma, J W Bloom, W R Roeske and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 173-180;
  5. Bonanno, G

    1. You have access
      Functional evidence for multiple gamma-aminobutyric acidB receptor subtypes in the rat cerebral cortex.
      G Bonanno and M Raiteri
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 114-118;
  6. Bowen, W D

    1. You have access
      Mediation of swim-stress antinociception by the opioid delta 2 receptor in the mouse.
      T W Vanderah, K D Wild, A E Takemori, M Sultana, P S Portoghese, W D Bowen, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 190-197;
    2. You have access
      Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors.
      W D Bowen, J M Walker, B R de Costa, R Wu, P J Tolentino, D Finn, R B Rothman and K C Rice
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 32-40;
  7. Branch, R A

    1. You have access
      Influence of the adenosine receptor antagonist, CGS 15943A, on renal function after reconstruction of chronic renal artery stenosis in the dog.
      B C Abels, J T Callis, R A Branch and R Sabra
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 166-172;
  8. Brewster, W K

    1. You have access
      Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
      D M Mottola, W K Brewster, L L Cook, D E Nichols and R B Mailman
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 383-393;
  9. Bristow, M R

    1. You have access
      Pharmacological characterization of chick and frog beta adrenergic receptors in primary cultures of myocardial cells.
      J D Port, C C Debellis, J Klein, G A Peeters, W H Barry and M R Bristow
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 217-224;

C

  1. Cai, Y

    1. You have access
      Age-associated enhancement of diquat-induced lipid peroxidation and cytotoxicity in isolated rat hepatocytes.
      L E Rikans and Y Cai
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 271-278;
  2. Callis, J T

    1. You have access
      Influence of the adenosine receptor antagonist, CGS 15943A, on renal function after reconstruction of chronic renal artery stenosis in the dog.
      B C Abels, J T Callis, R A Branch and R Sabra
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 166-172;
  3. Chakravarty, P K

    1. You have access
      In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.
      R S Chang, P K Siegl, B V Clineschmidt, N B Mantlo, P K Chakravarty, W J Greenlee, A A Patchett and V J Lotti
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 133-138;
    2. You have access
      In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
      P K Siegl, R S Chang, N B Mantlo, P K Chakravarty, D L Ondeyka, W J Greenlee, A A Patchett, C S Sweet and V J Lotti
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 139-144;
  4. Chang, K J

    1. You have access
      Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes.
      C S Wong, Y F Su, W D Watkins and K J Chang
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 317-326;
  5. Chang, R S

    1. You have access
      In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.
      R S Chang, P K Siegl, B V Clineschmidt, N B Mantlo, P K Chakravarty, W J Greenlee, A A Patchett and V J Lotti
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 133-138;
    2. You have access
      In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
      P K Siegl, R S Chang, N B Mantlo, P K Chakravarty, D L Ondeyka, W J Greenlee, A A Patchett, C S Sweet and V J Lotti
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 139-144;
  6. Chao, C C

    1. You have access
      Morphine potentiates transforming growth factor-beta release from human peripheral blood mononuclear cell cultures.
      C C Chao, S Hu, T W Molitor, Y Zhou, M P Murtaugh, M Tsang and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 19-24;
  7. Chen, X

    1. You have access
      Lisinopril and ramiprilat protection of the vascular endothelium against free radical-induced functional injury.
      C N Gillis, X Chen and M M Merker
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 212-216;
  8. Cho, A K

    1. You have access
      Effects of xylamine on vascular neuroeffector transmission.
      O A Nedergaard, A K Cho and L A Waggaman
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 231-237;
  9. Clineschmidt, B V

    1. You have access
      In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.
      R S Chang, P K Siegl, B V Clineschmidt, N B Mantlo, P K Chakravarty, W J Greenlee, A A Patchett and V J Lotti
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 133-138;
  10. Cook, L L

    1. You have access
      Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
      D M Mottola, W K Brewster, L L Cook, D E Nichols and R B Mailman
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 383-393;
  11. Costall, B

    1. You have access
      Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.
      B Costall, A M Domeney, A J Farre, M E Kelly, L Martinez and R J Naylor
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 90-98;
  12. Cox, B M

    1. You have access
      Serotonin-stimulated release of [3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: a comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and D-amphetamine.
      H M Jacocks and B M Cox
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 356-364;
  13. Cros, J

    1. You have access
      Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine.
      B Frances, R Gout, B Monsarrat, J Cros and J M Zajac
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 25-31;

D

  1. Debellis, C C

    1. You have access
      Pharmacological characterization of chick and frog beta adrenergic receptors in primary cultures of myocardial cells.
      J D Port, C C Debellis, J Klein, G A Peeters, W H Barry and M R Bristow
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 217-224;
  2. De Boer, S F

    1. You have access
      Common mechanisms underlying the proconflict effects of corticotropin-releasing factor, a benzodiazepine inverse agonist and electric foot-shock.
      S F De Boer, J L Katz and R J Valentino
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 335-342;
  3. de Costa, B R

    1. You have access
      Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors.
      W D Bowen, J M Walker, B R de Costa, R Wu, P J Tolentino, D Finn, R B Rothman and K C Rice
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 32-40;
  4. Di Monte, D A

    1. You have access
      Toxicity of the 1-methyl-4-phenyl-2,3-dihydropyridinium and 1-methyl-4-phenylpyridinium species in primary cultures of mouse astrocytes.
      E Y Wu, J W Langston and D A Di Monte
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 225-230;
  5. Ding, X

    1. You have access
      P-450-dependent arachidonic acid metabolism in rabbit olfactory microsomes.
      R M Laethem, C L Laethem, X Ding and D R Koop
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 433-438;
  6. Domeney, A M

    1. You have access
      Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.
      B Costall, A M Domeney, A J Farre, M E Kelly, L Martinez and R J Naylor
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 90-98;

E

  1. Edelman, A M

    1. You have access
      Activation of protein kinase A is necessary but not sufficient for ethanol-induced desensitization of cyclic AMP production.
      R A Rabin, A M Edelman and J A Wagner
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 257-262;
  2. el-Fakahany, E E

    1. You have access
      Modulation by certain conserved aspartate residues of the allosteric interaction of gallamine at the m1 muscarinic receptor.
      N H Lee, J Hu and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 312-316;
  3. el-Mas, M M

    1. You have access
      Role of aortic baroreceptors in ethanol-induced impairment of baroreflex control of heart rate in conscious rats.
      M M el-Mas and A A Abdel-Rahman
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 157-165;
  4. Elliott, W C

    1. You have access
      Aminoglycoside-mediated calciuresis.
      W C Elliott and D S Patchin
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 151-156;

F

  1. Farre, A J

    1. You have access
      Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.
      B Costall, A M Domeney, A J Farre, M E Kelly, L Martinez and R J Naylor
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 90-98;
  2. Fennell, S

    1. You have access
      Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
      A A Seymour, M M Asaad, B E Abboa-Offei, P L Rovnyak, S Fennell and W L Rogers
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 60-70;
  3. Fernandes, L B

    1. You have access
      M2 muscarinic receptors inhibit isoproterenol-induced relaxation of canine airway smooth muscle.
      L B Fernandes, A D Fryer and C A Hirshman
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 119-126;
  4. Findlay, I

    1. You have access
      Effects of pH upon the inhibition by sulphonylurea drugs of ATP-sensitive K+ channels in cardiac muscle.
      I Findlay
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 71-79;
  5. Finn, D

    1. You have access
      Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors.
      W D Bowen, J M Walker, B R de Costa, R Wu, P J Tolentino, D Finn, R B Rothman and K C Rice
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 32-40;
  6. Frances, B

    1. You have access
      Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine.
      B Frances, R Gout, B Monsarrat, J Cros and J M Zajac
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 25-31;
  7. Fryer, A D

    1. You have access
      M2 muscarinic receptors inhibit isoproterenol-induced relaxation of canine airway smooth muscle.
      L B Fernandes, A D Fryer and C A Hirshman
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 119-126;
  8. Fujii, T

    1. You have access
      FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
      H Morimoto, M Murai, Y Maeda, M Yamaoka, M Nishikawa, S Kiyotoh and T Fujii
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 398-402;
    2. You have access
      Effects of FK224, a novel compound NK1 and NK2 receptor antagonist, on airway constriction and airway edema induced by neurokinins and sensory nerve stimulation in guinea pigs.
      M Murai, H Morimoto, Y Maeda, S Kiyotoh, M Nishikawa and T Fujii
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 403-408;
  9. Fuller, S A

    1. You have access
      Selective effects of cocaine on regional cerebral blood flow in the rat.
      E A Stein and S A Fuller
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 327-334;

G

  1. Gaginella, T S

    1. You have access
      Endothelin-1 stimulates contraction and ion transport in the rat colon: different mechanisms of action.
      C Moummi, Y Xie, J F Kachur and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 409-414;
  2. Gavish, M

    1. You have access
      Disulfiram and diethyldithiocarbamate are competitive inhibitors at the peripheral benzodiazepine receptor.
      Y Katz, R Weizman, A Weizman and M Gavish
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 394-397;
  3. Gillis, C N

    1. You have access
      Lisinopril and ramiprilat protection of the vascular endothelium against free radical-induced functional injury.
      C N Gillis, X Chen and M M Merker
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 212-216;
  4. Giri, S N

    1. You have access
      Attenuation of amiodarone-induced lung fibrosis and phospholipidosis in hamsters by taurine and/or niacin treatment.
      Q Wang, M A Hollinger and S N Giri
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 127-132;
  5. Giuliani, S

    1. You have access
      Involvement of 5-hydroxytryptamine1A receptors in the modulation of micturition reflexes in the anesthetized rat.
      A Lecci, S Giuliani, P Santicioli and C A Maggi
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 181-189;
  6. Gout, R

    1. You have access
      Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine.
      B Frances, R Gout, B Monsarrat, J Cros and J M Zajac
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 25-31;
  7. Grady, T

    1. You have access
      In vivo and in vitro effects of the azidothymidine analog dideoxyinosine on the exocrine pancreas of the rat.
      T Grady, A K Saluja, M L Steer, M M Lerch, I M Modlin and R E Powers
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 445-449;
  8. Greenlee, W J

    1. You have access
      In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.
      R S Chang, P K Siegl, B V Clineschmidt, N B Mantlo, P K Chakravarty, W J Greenlee, A A Patchett and V J Lotti
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 133-138;
    2. You have access
      In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
      P K Siegl, R S Chang, N B Mantlo, P K Chakravarty, D L Ondeyka, W J Greenlee, A A Patchett, C S Sweet and V J Lotti
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 139-144;
  9. Gross, S S

    1. You have access
      A central nervous system action of nitric oxide in blood pressure regulation.
      H Togashi, I Sakuma, M Yoshioka, T Kobayashi, H Yasuda, A Kitabatake, H Saito, S S Gross and R Levi
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 343-347;

H

  1. Halushka, P V

    1. You have access
      Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
      A K Okwu, M E Ullian and P V Halushka
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 238-245;
  2. Hamaguchi, M

    1. You have access
      Involvement of charybdotoxin-sensitive K+ channel in the relaxation of bovine tracheal smooth muscle by glyceryl trinitrate and sodium nitroprusside.
      M Hamaguchi, T Ishibashi and S Imai
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 263-270;
  3. Hande, K R

    1. You have access
      Association between increased atrial natriuretic peptide and reduced cisplatin nephrotoxicity in rats.
      P M Ormond, M A Basinger, M M Jones and K R Hande
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 246-251;
  4. Harper, P A

    1. You have access
      Handling of digoxin and ouabain by renal tubular cells (LLC-PK1).
      S Ito, G Koren and P A Harper
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 109-113;
  5. Hillegaart, V

    1. You have access
      Relationship between brain levels of 3-(3-hydroxyphenyl)-N-n-propylpiperidine HCl enantiomers and effects on locomotor activity in rats.
      J Lundström, J E Lindgren, S Ahlenius and V Hillegaart
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 41-47;
  6. Hirota, K

    1. You have access
      Protective effects of (2E)-3-[5-(2,3-dimethoxy-6-methyl-1,4- benzoquinoyl)]-2-nonyl-2-propenoic acid on endotoxin-mediated hepatitis in mice.
      J Nagakawa, I Hishinuma, K Miyamoto, K Hirota, S Abe, T Yamanaka, K Katayama and I Yamatsu
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 145-150;
  7. Hirshman, C A

    1. You have access
      M2 muscarinic receptors inhibit isoproterenol-induced relaxation of canine airway smooth muscle.
      L B Fernandes, A D Fryer and C A Hirshman
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 119-126;
  8. Hishinuma, I

    1. You have access
      Protective effects of (2E)-3-[5-(2,3-dimethoxy-6-methyl-1,4- benzoquinoyl)]-2-nonyl-2-propenoic acid on endotoxin-mediated hepatitis in mice.
      J Nagakawa, I Hishinuma, K Miyamoto, K Hirota, S Abe, T Yamanaka, K Katayama and I Yamatsu
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 145-150;
  9. Hollinger, M A

    1. You have access
      Attenuation of amiodarone-induced lung fibrosis and phospholipidosis in hamsters by taurine and/or niacin treatment.
      Q Wang, M A Hollinger and S N Giri
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 127-132;
  10. Holtzman, S G

    1. You have access
      Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats.
      C A Paronis and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 1-9;
  11. Hu, J

    1. You have access
      Modulation by certain conserved aspartate residues of the allosteric interaction of gallamine at the m1 muscarinic receptor.
      N H Lee, J Hu and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 312-316;
  12. Hu, S

    1. You have access
      Morphine potentiates transforming growth factor-beta release from human peripheral blood mononuclear cell cultures.
      C C Chao, S Hu, T W Molitor, Y Zhou, M P Murtaugh, M Tsang and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 19-24;
  13. Hylden, J K

    1. You have access
      Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
      S C Roerig, S Lei, K Kitto, J K Hylden and G L Wilcox
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 365-374;

I

  1. Ibrahim, S

    1. You have access
      Comparative assessment of poly-L-aspartic and poly-L-glutamic acids as protectants against gentamicin-induced renal lysosomal phospholipidosis, phospholipiduria and cell proliferation in rats.
      B K Kishore, S Ibrahim, P Lambricht, G Laurent, P Maldague and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 424-432;
  2. Imai, S

    1. You have access
      Involvement of charybdotoxin-sensitive K+ channel in the relaxation of bovine tracheal smooth muscle by glyceryl trinitrate and sodium nitroprusside.
      M Hamaguchi, T Ishibashi and S Imai
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 263-270;
  3. Ishibashi, T

    1. You have access
      Involvement of charybdotoxin-sensitive K+ channel in the relaxation of bovine tracheal smooth muscle by glyceryl trinitrate and sodium nitroprusside.
      M Hamaguchi, T Ishibashi and S Imai
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 263-270;
  4. Ito, S

    1. You have access
      Handling of digoxin and ouabain by renal tubular cells (LLC-PK1).
      S Ito, G Koren and P A Harper
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 109-113;

J

  1. Jackson, R H

    1. You have access
      Comparison of antagonist and agonist binding to the leukotriene B4 receptor intact human polymorphonuclear neutrophils (PMN).
      R H Jackson, M M Morrissey, M A Sills and M F Jarvis
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 80-89;
  2. Jacocks, H M

    1. You have access
      Serotonin-stimulated release of [3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: a comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and D-amphetamine.
      H M Jacocks and B M Cox
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 356-364;
  3. Jarvis, M F

    1. You have access
      Comparison of antagonist and agonist binding to the leukotriene B4 receptor intact human polymorphonuclear neutrophils (PMN).
      R H Jackson, M M Morrissey, M A Sills and M F Jarvis
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 80-89;
  4. Jones, M M

    1. You have access
      Association between increased atrial natriuretic peptide and reduced cisplatin nephrotoxicity in rats.
      P M Ormond, M A Basinger, M M Jones and K R Hande
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 246-251;

K

  1. Kachur, J F

    1. You have access
      Endothelin-1 stimulates contraction and ion transport in the rat colon: different mechanisms of action.
      C Moummi, Y Xie, J F Kachur and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 409-414;
  2. Kaneko, T

    1. You have access
      Pharmacokinetic and pharmacodynamic comparisons between human granulocyte colony-stimulating factor purified from human bladder carcinoma cell line 5637 culture medium and recombinant human granulocyte colony-stimulating factor produced in Escherichia coli.
      H Tanaka and T Kaneko
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 439-444;
  3. Katayama, K

    1. You have access
      Protective effects of (2E)-3-[5-(2,3-dimethoxy-6-methyl-1,4- benzoquinoyl)]-2-nonyl-2-propenoic acid on endotoxin-mediated hepatitis in mice.
      J Nagakawa, I Hishinuma, K Miyamoto, K Hirota, S Abe, T Yamanaka, K Katayama and I Yamatsu
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 145-150;
  4. Katz, J L

    1. You have access
      Common mechanisms underlying the proconflict effects of corticotropin-releasing factor, a benzodiazepine inverse agonist and electric foot-shock.
      S F De Boer, J L Katz and R J Valentino
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 335-342;
  5. Katz, Y

    1. You have access
      Disulfiram and diethyldithiocarbamate are competitive inhibitors at the peripheral benzodiazepine receptor.
      Y Katz, R Weizman, A Weizman and M Gavish
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 394-397;
  6. Kelly, M E

    1. You have access
      Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.
      B Costall, A M Domeney, A J Farre, M E Kelly, L Martinez and R J Naylor
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 90-98;
  7. Kishore, B K

    1. You have access
      Comparative assessment of poly-L-aspartic and poly-L-glutamic acids as protectants against gentamicin-induced renal lysosomal phospholipidosis, phospholipiduria and cell proliferation in rats.
      B K Kishore, S Ibrahim, P Lambricht, G Laurent, P Maldague and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 424-432;
  8. Kitabatake, A

    1. You have access
      A central nervous system action of nitric oxide in blood pressure regulation.
      H Togashi, I Sakuma, M Yoshioka, T Kobayashi, H Yasuda, A Kitabatake, H Saito, S S Gross and R Levi
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 343-347;
  9. Kitto, K

    1. You have access
      Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
      S C Roerig, S Lei, K Kitto, J K Hylden and G L Wilcox
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 365-374;
  10. Kiyotoh, S

    1. You have access
      FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
      H Morimoto, M Murai, Y Maeda, M Yamaoka, M Nishikawa, S Kiyotoh and T Fujii
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 398-402;
    2. You have access
      Effects of FK224, a novel compound NK1 and NK2 receptor antagonist, on airway constriction and airway edema induced by neurokinins and sensory nerve stimulation in guinea pigs.
      M Murai, H Morimoto, Y Maeda, S Kiyotoh, M Nishikawa and T Fujii
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 403-408;
  11. Klein, J

    1. You have access
      Pharmacological characterization of chick and frog beta adrenergic receptors in primary cultures of myocardial cells.
      J D Port, C C Debellis, J Klein, G A Peeters, W H Barry and M R Bristow
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 217-224;
  12. Kobayashi, T

    1. You have access
      A central nervous system action of nitric oxide in blood pressure regulation.
      H Togashi, I Sakuma, M Yoshioka, T Kobayashi, H Yasuda, A Kitabatake, H Saito, S S Gross and R Levi
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 343-347;
  13. Koop, D R

    1. You have access
      P-450-dependent arachidonic acid metabolism in rabbit olfactory microsomes.
      R M Laethem, C L Laethem, X Ding and D R Koop
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 433-438;
  14. Koren, G

    1. You have access
      Handling of digoxin and ouabain by renal tubular cells (LLC-PK1).
      S Ito, G Koren and P A Harper
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 109-113;

L

  1. Laethem, C L

    1. You have access
      P-450-dependent arachidonic acid metabolism in rabbit olfactory microsomes.
      R M Laethem, C L Laethem, X Ding and D R Koop
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 433-438;
  2. Laethem, R M

    1. You have access
      P-450-dependent arachidonic acid metabolism in rabbit olfactory microsomes.
      R M Laethem, C L Laethem, X Ding and D R Koop
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 433-438;
  3. Lai, J

    1. You have access
      Chimeric M1/M2 muscarinic receptors: correlation of ligand selectivity and functional coupling with structural modifications.
      J Lai, L Nunan, S L Waite, S W Ma, J W Bloom, W R Roeske and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 173-180;
  4. Lambricht, P

    1. You have access
      Comparative assessment of poly-L-aspartic and poly-L-glutamic acids as protectants against gentamicin-induced renal lysosomal phospholipidosis, phospholipiduria and cell proliferation in rats.
      B K Kishore, S Ibrahim, P Lambricht, G Laurent, P Maldague and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 424-432;
  5. Langston, J W

    1. You have access
      Toxicity of the 1-methyl-4-phenyl-2,3-dihydropyridinium and 1-methyl-4-phenylpyridinium species in primary cultures of mouse astrocytes.
      E Y Wu, J W Langston and D A Di Monte
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 225-230;
  6. Laurent, G

    1. You have access
      Comparative assessment of poly-L-aspartic and poly-L-glutamic acids as protectants against gentamicin-induced renal lysosomal phospholipidosis, phospholipiduria and cell proliferation in rats.
      B K Kishore, S Ibrahim, P Lambricht, G Laurent, P Maldague and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 424-432;
  7. Lazzara, R

    1. You have access
      Electrophysiologic actions of clofilium and lidocaine in ischemically injured canine epicardium.
      E Patterson, B J Scherlag and R Lazzara
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 375-382;
  8. Lecci, A

    1. You have access
      Involvement of 5-hydroxytryptamine1A receptors in the modulation of micturition reflexes in the anesthetized rat.
      A Lecci, S Giuliani, P Santicioli and C A Maggi
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 181-189;
  9. Lee, K S

    1. You have access
      Ibutilide, a new compound with potent class III antiarrhythmic activity, activates a slow inward Na+ current in guinea pig ventricular cells.
      K S Lee
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 99-108;
  10. Lee, N H

    1. You have access
      Modulation by certain conserved aspartate residues of the allosteric interaction of gallamine at the m1 muscarinic receptor.
      N H Lee, J Hu and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 312-316;
  11. Lei, S

    1. You have access
      Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
      S C Roerig, S Lei, K Kitto, J K Hylden and G L Wilcox
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 365-374;
  12. Lerch, M M

    1. You have access
      In vivo and in vitro effects of the azidothymidine analog dideoxyinosine on the exocrine pancreas of the rat.
      T Grady, A K Saluja, M L Steer, M M Lerch, I M Modlin and R E Powers
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 445-449;
  13. Levant, B

    1. You have access
      Further studies on the modulation of regional brain neurotensin concentrations by antipsychotic drugs: focus on haloperidol and BMY 14802.
      B Levant and C B Nemeroff
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 348-355;
  14. Levi, R

    1. You have access
      A central nervous system action of nitric oxide in blood pressure regulation.
      H Togashi, I Sakuma, M Yoshioka, T Kobayashi, H Yasuda, A Kitabatake, H Saito, S S Gross and R Levi
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 343-347;
  15. Lindgren, J E

    1. You have access
      Relationship between brain levels of 3-(3-hydroxyphenyl)-N-n-propylpiperidine HCl enantiomers and effects on locomotor activity in rats.
      J Lundström, J E Lindgren, S Ahlenius and V Hillegaart
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 41-47;
  16. Lotti, V J

    1. You have access
      In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.
      R S Chang, P K Siegl, B V Clineschmidt, N B Mantlo, P K Chakravarty, W J Greenlee, A A Patchett and V J Lotti
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 133-138;
    2. You have access
      In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
      P K Siegl, R S Chang, N B Mantlo, P K Chakravarty, D L Ondeyka, W J Greenlee, A A Patchett, C S Sweet and V J Lotti
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 139-144;
  17. Lundström, J

    1. You have access
      Relationship between brain levels of 3-(3-hydroxyphenyl)-N-n-propylpiperidine HCl enantiomers and effects on locomotor activity in rats.
      J Lundström, J E Lindgren, S Ahlenius and V Hillegaart
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 41-47;

M

  1. Ma, S W

    1. You have access
      Chimeric M1/M2 muscarinic receptors: correlation of ligand selectivity and functional coupling with structural modifications.
      J Lai, L Nunan, S L Waite, S W Ma, J W Bloom, W R Roeske and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 173-180;
  2. Maeda, Y

    1. You have access
      FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
      H Morimoto, M Murai, Y Maeda, M Yamaoka, M Nishikawa, S Kiyotoh and T Fujii
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 398-402;
    2. You have access
      Effects of FK224, a novel compound NK1 and NK2 receptor antagonist, on airway constriction and airway edema induced by neurokinins and sensory nerve stimulation in guinea pigs.
      M Murai, H Morimoto, Y Maeda, S Kiyotoh, M Nishikawa and T Fujii
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 403-408;
  3. Maggi, C A

    1. You have access
      Involvement of 5-hydroxytryptamine1A receptors in the modulation of micturition reflexes in the anesthetized rat.
      A Lecci, S Giuliani, P Santicioli and C A Maggi
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 181-189;
  4. Mailman, R B

    1. You have access
      Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
      D M Mottola, W K Brewster, L L Cook, D E Nichols and R B Mailman
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 383-393;
  5. Maldague, P

    1. You have access
      Comparative assessment of poly-L-aspartic and poly-L-glutamic acids as protectants against gentamicin-induced renal lysosomal phospholipidosis, phospholipiduria and cell proliferation in rats.
      B K Kishore, S Ibrahim, P Lambricht, G Laurent, P Maldague and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 424-432;
  6. Mantlo, N B

    1. You have access
      In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.
      R S Chang, P K Siegl, B V Clineschmidt, N B Mantlo, P K Chakravarty, W J Greenlee, A A Patchett and V J Lotti
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 133-138;
    2. You have access
      In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
      P K Siegl, R S Chang, N B Mantlo, P K Chakravarty, D L Ondeyka, W J Greenlee, A A Patchett, C S Sweet and V J Lotti
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 139-144;
  7. Martinez, L

    1. You have access
      Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.
      B Costall, A M Domeney, A J Farre, M E Kelly, L Martinez and R J Naylor
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 90-98;
  8. McGiff, J C

    1. You have access
      Endothelin-3 effects on renal function and prostanoid release in the rat isolated kidney.
      C T Stier, C P Quilley and J C McGiff
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 252-256;
  9. Merker, M M

    1. You have access
      Lisinopril and ramiprilat protection of the vascular endothelium against free radical-induced functional injury.
      C N Gillis, X Chen and M M Merker
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 212-216;
  10. Miyamoto, K

    1. You have access
      Protective effects of (2E)-3-[5-(2,3-dimethoxy-6-methyl-1,4- benzoquinoyl)]-2-nonyl-2-propenoic acid on endotoxin-mediated hepatitis in mice.
      J Nagakawa, I Hishinuma, K Miyamoto, K Hirota, S Abe, T Yamanaka, K Katayama and I Yamatsu
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 145-150;
  11. Modlin, I M

    1. You have access
      In vivo and in vitro effects of the azidothymidine analog dideoxyinosine on the exocrine pancreas of the rat.
      T Grady, A K Saluja, M L Steer, M M Lerch, I M Modlin and R E Powers
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 445-449;
  12. Molitor, T W

    1. You have access
      Morphine potentiates transforming growth factor-beta release from human peripheral blood mononuclear cell cultures.
      C C Chao, S Hu, T W Molitor, Y Zhou, M P Murtaugh, M Tsang and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 19-24;
  13. Monsarrat, B

    1. You have access
      Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine.
      B Frances, R Gout, B Monsarrat, J Cros and J M Zajac
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 25-31;
  14. Morimoto, H

    1. You have access
      FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
      H Morimoto, M Murai, Y Maeda, M Yamaoka, M Nishikawa, S Kiyotoh and T Fujii
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 398-402;
    2. You have access
      Effects of FK224, a novel compound NK1 and NK2 receptor antagonist, on airway constriction and airway edema induced by neurokinins and sensory nerve stimulation in guinea pigs.
      M Murai, H Morimoto, Y Maeda, S Kiyotoh, M Nishikawa and T Fujii
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 403-408;
  15. Morrissey, M M

    1. You have access
      Comparison of antagonist and agonist binding to the leukotriene B4 receptor intact human polymorphonuclear neutrophils (PMN).
      R H Jackson, M M Morrissey, M A Sills and M F Jarvis
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 80-89;
  16. Mosberg, H I

    1. You have access
      Mediation of swim-stress antinociception by the opioid delta 2 receptor in the mouse.
      T W Vanderah, K D Wild, A E Takemori, M Sultana, P S Portoghese, W D Bowen, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 190-197;
  17. Mottola, D M

    1. You have access
      Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
      D M Mottola, W K Brewster, L L Cook, D E Nichols and R B Mailman
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 383-393;
  18. Moummi, C

    1. You have access
      Endothelin-1 stimulates contraction and ion transport in the rat colon: different mechanisms of action.
      C Moummi, Y Xie, J F Kachur and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 409-414;
  19. Murai, M

    1. You have access
      FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
      H Morimoto, M Murai, Y Maeda, M Yamaoka, M Nishikawa, S Kiyotoh and T Fujii
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 398-402;
    2. You have access
      Effects of FK224, a novel compound NK1 and NK2 receptor antagonist, on airway constriction and airway edema induced by neurokinins and sensory nerve stimulation in guinea pigs.
      M Murai, H Morimoto, Y Maeda, S Kiyotoh, M Nishikawa and T Fujii
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 403-408;
  20. Murtaugh, M P

    1. You have access
      Morphine potentiates transforming growth factor-beta release from human peripheral blood mononuclear cell cultures.
      C C Chao, S Hu, T W Molitor, Y Zhou, M P Murtaugh, M Tsang and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 19-24;

N

  1. Nagakawa, J

    1. You have access
      Protective effects of (2E)-3-[5-(2,3-dimethoxy-6-methyl-1,4- benzoquinoyl)]-2-nonyl-2-propenoic acid on endotoxin-mediated hepatitis in mice.
      J Nagakawa, I Hishinuma, K Miyamoto, K Hirota, S Abe, T Yamanaka, K Katayama and I Yamatsu
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 145-150;
  2. Naylor, R J

    1. You have access
      Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.
      B Costall, A M Domeney, A J Farre, M E Kelly, L Martinez and R J Naylor
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 90-98;
  3. Nedergaard, O A

    1. You have access
      Effects of xylamine on vascular neuroeffector transmission.
      O A Nedergaard, A K Cho and L A Waggaman
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 231-237;
  4. Nemeroff, C B

    1. You have access
      Further studies on the modulation of regional brain neurotensin concentrations by antipsychotic drugs: focus on haloperidol and BMY 14802.
      B Levant and C B Nemeroff
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 348-355;
  5. Nichols, D E

    1. You have access
      Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
      D M Mottola, W K Brewster, L L Cook, D E Nichols and R B Mailman
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 383-393;
  6. Nishikawa, M

    1. You have access
      FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
      H Morimoto, M Murai, Y Maeda, M Yamaoka, M Nishikawa, S Kiyotoh and T Fujii
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 398-402;
    2. You have access
      Effects of FK224, a novel compound NK1 and NK2 receptor antagonist, on airway constriction and airway edema induced by neurokinins and sensory nerve stimulation in guinea pigs.
      M Murai, H Morimoto, Y Maeda, S Kiyotoh, M Nishikawa and T Fujii
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 403-408;
  7. Nunan, L

    1. You have access
      Chimeric M1/M2 muscarinic receptors: correlation of ligand selectivity and functional coupling with structural modifications.
      J Lai, L Nunan, S L Waite, S W Ma, J W Bloom, W R Roeske and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 173-180;

O

  1. Okwu, A K

    1. You have access
      Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
      A K Okwu, M E Ullian and P V Halushka
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 238-245;
  2. Ondeyka, D L

    1. You have access
      In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
      P K Siegl, R S Chang, N B Mantlo, P K Chakravarty, D L Ondeyka, W J Greenlee, A A Patchett, C S Sweet and V J Lotti
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 139-144;
  3. Ormond, P M

    1. You have access
      Association between increased atrial natriuretic peptide and reduced cisplatin nephrotoxicity in rats.
      P M Ormond, M A Basinger, M M Jones and K R Hande
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 246-251;

P

  1. Paronis, C A

    1. You have access
      Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats.
      C A Paronis and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 1-9;
  2. Patchett, A A

    1. You have access
      In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.
      R S Chang, P K Siegl, B V Clineschmidt, N B Mantlo, P K Chakravarty, W J Greenlee, A A Patchett and V J Lotti
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 133-138;
    2. You have access
      In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
      P K Siegl, R S Chang, N B Mantlo, P K Chakravarty, D L Ondeyka, W J Greenlee, A A Patchett, C S Sweet and V J Lotti
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 139-144;
  3. Patchin, D S

    1. You have access
      Aminoglycoside-mediated calciuresis.
      W C Elliott and D S Patchin
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 151-156;
  4. Patterson, E

    1. You have access
      Electrophysiologic actions of clofilium and lidocaine in ischemically injured canine epicardium.
      E Patterson, B J Scherlag and R Lazzara
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 375-382;
  5. Peeters, G A

    1. You have access
      Pharmacological characterization of chick and frog beta adrenergic receptors in primary cultures of myocardial cells.
      J D Port, C C Debellis, J Klein, G A Peeters, W H Barry and M R Bristow
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 217-224;
  6. Peterson, P K

    1. You have access
      Morphine potentiates transforming growth factor-beta release from human peripheral blood mononuclear cell cultures.
      C C Chao, S Hu, T W Molitor, Y Zhou, M P Murtaugh, M Tsang and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 19-24;
  7. Porreca, F

    1. You have access
      Mediation of swim-stress antinociception by the opioid delta 2 receptor in the mouse.
      T W Vanderah, K D Wild, A E Takemori, M Sultana, P S Portoghese, W D Bowen, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 190-197;
  8. Port, J D

    1. You have access
      Pharmacological characterization of chick and frog beta adrenergic receptors in primary cultures of myocardial cells.
      J D Port, C C Debellis, J Klein, G A Peeters, W H Barry and M R Bristow
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 217-224;
  9. Portoghese, P S

    1. You have access
      Mediation of swim-stress antinociception by the opioid delta 2 receptor in the mouse.
      T W Vanderah, K D Wild, A E Takemori, M Sultana, P S Portoghese, W D Bowen, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 190-197;
  10. Powers, R E

    1. You have access
      In vivo and in vitro effects of the azidothymidine analog dideoxyinosine on the exocrine pancreas of the rat.
      T Grady, A K Saluja, M L Steer, M M Lerch, I M Modlin and R E Powers
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 445-449;
  11. Preston, K L

    1. You have access
      Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers.
      K L Preston, J T Sullivan, E C Strain and G E Bigelow
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 279-291;
  12. Prins, B A

    1. You have access
      Norepinephrine amplifies angiotensin II-induced vasoconstriction in rabbit femoral artery.
      B A Prins, M A Weber and R E Purdy
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 198-203;
  13. Purdy, R E

    1. You have access
      Norepinephrine amplifies angiotensin II-induced vasoconstriction in rabbit femoral artery.
      B A Prins, M A Weber and R E Purdy
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 198-203;

Q

  1. Quilley, C P

    1. You have access
      Endothelin-3 effects on renal function and prostanoid release in the rat isolated kidney.
      C T Stier, C P Quilley and J C McGiff
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 252-256;

R

  1. Rabin, R A

    1. You have access
      Activation of protein kinase A is necessary but not sufficient for ethanol-induced desensitization of cyclic AMP production.
      R A Rabin, A M Edelman and J A Wagner
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 257-262;
  2. Raiteri, M

    1. You have access
      Functional evidence for multiple gamma-aminobutyric acidB receptor subtypes in the rat cerebral cortex.
      G Bonanno and M Raiteri
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 114-118;
  3. Rice, K C

    1. You have access
      Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors.
      W D Bowen, J M Walker, B R de Costa, R Wu, P J Tolentino, D Finn, R B Rothman and K C Rice
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 32-40;
  4. Rikans, L E

    1. You have access
      Age-associated enhancement of diquat-induced lipid peroxidation and cytotoxicity in isolated rat hepatocytes.
      L E Rikans and Y Cai
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 271-278;
  5. Roerig, S C

    1. You have access
      Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
      S C Roerig, S Lei, K Kitto, J K Hylden and G L Wilcox
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 365-374;
  6. Roeske, W R

    1. You have access
      Chimeric M1/M2 muscarinic receptors: correlation of ligand selectivity and functional coupling with structural modifications.
      J Lai, L Nunan, S L Waite, S W Ma, J W Bloom, W R Roeske and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 173-180;
  7. Rogers, W L

    1. You have access
      Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
      A A Seymour, M M Asaad, B E Abboa-Offei, P L Rovnyak, S Fennell and W L Rogers
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 60-70;
  8. Rothman, R B

    1. You have access
      Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors.
      W D Bowen, J M Walker, B R de Costa, R Wu, P J Tolentino, D Finn, R B Rothman and K C Rice
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 32-40;
  9. Rovnyak, P L

    1. You have access
      Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
      A A Seymour, M M Asaad, B E Abboa-Offei, P L Rovnyak, S Fennell and W L Rogers
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 60-70;
  10. Rurak, D W

    1. You have access
      Metabolic effects of ritodrine in the fetal lamb.
      M P van der Weyde, M R Wright, S M Taylor, J E Axelson and D W Rurak
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 48-59;

S

  1. Sabra, R

    1. You have access
      Influence of the adenosine receptor antagonist, CGS 15943A, on renal function after reconstruction of chronic renal artery stenosis in the dog.
      B C Abels, J T Callis, R A Branch and R Sabra
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 166-172;
  2. Saito, H

    1. You have access
      A central nervous system action of nitric oxide in blood pressure regulation.
      H Togashi, I Sakuma, M Yoshioka, T Kobayashi, H Yasuda, A Kitabatake, H Saito, S S Gross and R Levi
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 343-347;
  3. Sakuma, I

    1. You have access
      A central nervous system action of nitric oxide in blood pressure regulation.
      H Togashi, I Sakuma, M Yoshioka, T Kobayashi, H Yasuda, A Kitabatake, H Saito, S S Gross and R Levi
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 343-347;
  4. Saluja, A K

    1. You have access
      In vivo and in vitro effects of the azidothymidine analog dideoxyinosine on the exocrine pancreas of the rat.
      T Grady, A K Saluja, M L Steer, M M Lerch, I M Modlin and R E Powers
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 445-449;
  5. Santicioli, P

    1. You have access
      Involvement of 5-hydroxytryptamine1A receptors in the modulation of micturition reflexes in the anesthetized rat.
      A Lecci, S Giuliani, P Santicioli and C A Maggi
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 181-189;
  6. Scherlag, B J

    1. You have access
      Electrophysiologic actions of clofilium and lidocaine in ischemically injured canine epicardium.
      E Patterson, B J Scherlag and R Lazzara
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 375-382;
  7. Schröder, H

    1. You have access
      Cytochrome P-450 mediates bioactivation of organic nitrates.
      H Schröder
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 298-302;
  8. Schulz, R

    1. You have access
      Neuroanatomical sites mediating the central actions of beta-endorphin as mapped by changes in glucose utilization: involvement of mu opioid receptors.
      A Ableitner and R Schulz
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 415-423;
  9. Seymour, A A

    1. You have access
      Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
      A A Seymour, M M Asaad, B E Abboa-Offei, P L Rovnyak, S Fennell and W L Rogers
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 60-70;
  10. Siegl, P K

    1. You have access
      In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.
      R S Chang, P K Siegl, B V Clineschmidt, N B Mantlo, P K Chakravarty, W J Greenlee, A A Patchett and V J Lotti
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 133-138;
    2. You have access
      In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
      P K Siegl, R S Chang, N B Mantlo, P K Chakravarty, D L Ondeyka, W J Greenlee, A A Patchett, C S Sweet and V J Lotti
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 139-144;
  11. Sills, M A

    1. You have access
      Comparison of antagonist and agonist binding to the leukotriene B4 receptor intact human polymorphonuclear neutrophils (PMN).
      R H Jackson, M M Morrissey, M A Sills and M F Jarvis
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 80-89;
  12. Steer, M L

    1. You have access
      In vivo and in vitro effects of the azidothymidine analog dideoxyinosine on the exocrine pancreas of the rat.
      T Grady, A K Saluja, M L Steer, M M Lerch, I M Modlin and R E Powers
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 445-449;
  13. Stein, E A

    1. You have access
      Selective effects of cocaine on regional cerebral blood flow in the rat.
      E A Stein and S A Fuller
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 327-334;
  14. Stevens, D L

    1. You have access
      Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice.
      S P Welch and D L Stevens
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 10-18;
  15. Stier, C T

    1. You have access
      Endothelin-3 effects on renal function and prostanoid release in the rat isolated kidney.
      C T Stier, C P Quilley and J C McGiff
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 252-256;
  16. Strain, E C

    1. You have access
      Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers.
      K L Preston, J T Sullivan, E C Strain and G E Bigelow
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 279-291;
  17. Su, Y F

    1. You have access
      Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes.
      C S Wong, Y F Su, W D Watkins and K J Chang
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 317-326;
  18. Sullivan, J T

    1. You have access
      Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers.
      K L Preston, J T Sullivan, E C Strain and G E Bigelow
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 279-291;
  19. Sultana, M

    1. You have access
      Mediation of swim-stress antinociception by the opioid delta 2 receptor in the mouse.
      T W Vanderah, K D Wild, A E Takemori, M Sultana, P S Portoghese, W D Bowen, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 190-197;
  20. Sweet, C S

    1. You have access
      In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
      P K Siegl, R S Chang, N B Mantlo, P K Chakravarty, D L Ondeyka, W J Greenlee, A A Patchett, C S Sweet and V J Lotti
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 139-144;

T

  1. Takemori, A E

    1. You have access
      Mediation of swim-stress antinociception by the opioid delta 2 receptor in the mouse.
      T W Vanderah, K D Wild, A E Takemori, M Sultana, P S Portoghese, W D Bowen, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 190-197;
  2. Tanaka, H

    1. You have access
      Pharmacokinetic and pharmacodynamic comparisons between human granulocyte colony-stimulating factor purified from human bladder carcinoma cell line 5637 culture medium and recombinant human granulocyte colony-stimulating factor produced in Escherichia coli.
      H Tanaka and T Kaneko
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 439-444;
  3. Taylor, S M

    1. You have access
      Metabolic effects of ritodrine in the fetal lamb.
      M P van der Weyde, M R Wright, S M Taylor, J E Axelson and D W Rurak
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 48-59;
  4. Tietz, E I

    1. You have access
      Reduction in potency of selective gamma-aminobutyric acidA agonists and diazepam in CA1 region of in vitro hippocampal slices from chronic flurazepam-treated rats.
      X H Xie and E I Tietz
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 204-211;
  5. Togashi, H

    1. You have access
      A central nervous system action of nitric oxide in blood pressure regulation.
      H Togashi, I Sakuma, M Yoshioka, T Kobayashi, H Yasuda, A Kitabatake, H Saito, S S Gross and R Levi
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 343-347;
  6. Tolentino, P J

    1. You have access
      Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors.
      W D Bowen, J M Walker, B R de Costa, R Wu, P J Tolentino, D Finn, R B Rothman and K C Rice
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 32-40;
  7. Tsang, M

    1. You have access
      Morphine potentiates transforming growth factor-beta release from human peripheral blood mononuclear cell cultures.
      C C Chao, S Hu, T W Molitor, Y Zhou, M P Murtaugh, M Tsang and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 19-24;
  8. Tulkens, P M

    1. You have access
      Comparative assessment of poly-L-aspartic and poly-L-glutamic acids as protectants against gentamicin-induced renal lysosomal phospholipidosis, phospholipiduria and cell proliferation in rats.
      B K Kishore, S Ibrahim, P Lambricht, G Laurent, P Maldague and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 424-432;

U

  1. Ullian, M E

    1. You have access
      Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
      A K Okwu, M E Ullian and P V Halushka
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 238-245;

V

  1. Valentino, R J

    1. You have access
      Common mechanisms underlying the proconflict effects of corticotropin-releasing factor, a benzodiazepine inverse agonist and electric foot-shock.
      S F De Boer, J L Katz and R J Valentino
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 335-342;
  2. van den Buuse, M

    1. You have access
      Central effects of quinpirole on blood pressure of spontaneously hypertensive rats.
      M van den Buuse
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 303-311;
  3. Vanderah, T W

    1. You have access
      Mediation of swim-stress antinociception by the opioid delta 2 receptor in the mouse.
      T W Vanderah, K D Wild, A E Takemori, M Sultana, P S Portoghese, W D Bowen, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 190-197;
  4. van der Weyde, M P

    1. You have access
      Metabolic effects of ritodrine in the fetal lamb.
      M P van der Weyde, M R Wright, S M Taylor, J E Axelson and D W Rurak
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 48-59;

W

  1. Waggaman, L A

    1. You have access
      Effects of xylamine on vascular neuroeffector transmission.
      O A Nedergaard, A K Cho and L A Waggaman
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 231-237;
  2. Wagner, J A

    1. You have access
      Activation of protein kinase A is necessary but not sufficient for ethanol-induced desensitization of cyclic AMP production.
      R A Rabin, A M Edelman and J A Wagner
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 257-262;
  3. Waite, S L

    1. You have access
      Chimeric M1/M2 muscarinic receptors: correlation of ligand selectivity and functional coupling with structural modifications.
      J Lai, L Nunan, S L Waite, S W Ma, J W Bloom, W R Roeske and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 173-180;
  4. Walker, J M

    1. You have access
      Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors.
      W D Bowen, J M Walker, B R de Costa, R Wu, P J Tolentino, D Finn, R B Rothman and K C Rice
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 32-40;
  5. Wang, Q

    1. You have access
      Attenuation of amiodarone-induced lung fibrosis and phospholipidosis in hamsters by taurine and/or niacin treatment.
      Q Wang, M A Hollinger and S N Giri
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 127-132;
  6. Watkins, W D

    1. You have access
      Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes.
      C S Wong, Y F Su, W D Watkins and K J Chang
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 317-326;
  7. Weber, M A

    1. You have access
      Norepinephrine amplifies angiotensin II-induced vasoconstriction in rabbit femoral artery.
      B A Prins, M A Weber and R E Purdy
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 198-203;
  8. Weizman, A

    1. You have access
      Disulfiram and diethyldithiocarbamate are competitive inhibitors at the peripheral benzodiazepine receptor.
      Y Katz, R Weizman, A Weizman and M Gavish
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 394-397;
  9. Weizman, R

    1. You have access
      Disulfiram and diethyldithiocarbamate are competitive inhibitors at the peripheral benzodiazepine receptor.
      Y Katz, R Weizman, A Weizman and M Gavish
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 394-397;
  10. Welch, S P

    1. You have access
      Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice.
      S P Welch and D L Stevens
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 10-18;
  11. Wilcox, G L

    1. You have access
      Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
      S C Roerig, S Lei, K Kitto, J K Hylden and G L Wilcox
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 365-374;
  12. Wild, K D

    1. You have access
      Mediation of swim-stress antinociception by the opioid delta 2 receptor in the mouse.
      T W Vanderah, K D Wild, A E Takemori, M Sultana, P S Portoghese, W D Bowen, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 190-197;
  13. Wong, C S

    1. You have access
      Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes.
      C S Wong, Y F Su, W D Watkins and K J Chang
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 317-326;
  14. Wright, M R

    1. You have access
      Metabolic effects of ritodrine in the fetal lamb.
      M P van der Weyde, M R Wright, S M Taylor, J E Axelson and D W Rurak
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 48-59;
  15. Wu, E Y

    1. You have access
      Toxicity of the 1-methyl-4-phenyl-2,3-dihydropyridinium and 1-methyl-4-phenylpyridinium species in primary cultures of mouse astrocytes.
      E Y Wu, J W Langston and D A Di Monte
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 225-230;
  16. Wu, R

    1. You have access
      Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors.
      W D Bowen, J M Walker, B R de Costa, R Wu, P J Tolentino, D Finn, R B Rothman and K C Rice
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 32-40;

X

  1. Xie, X H

    1. You have access
      Reduction in potency of selective gamma-aminobutyric acidA agonists and diazepam in CA1 region of in vitro hippocampal slices from chronic flurazepam-treated rats.
      X H Xie and E I Tietz
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 204-211;
  2. Xie, Y

    1. You have access
      Endothelin-1 stimulates contraction and ion transport in the rat colon: different mechanisms of action.
      C Moummi, Y Xie, J F Kachur and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 409-414;

Y

  1. Yamamura, H I

    1. You have access
      Chimeric M1/M2 muscarinic receptors: correlation of ligand selectivity and functional coupling with structural modifications.
      J Lai, L Nunan, S L Waite, S W Ma, J W Bloom, W R Roeske and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 173-180;
  2. Yamanaka, T

    1. You have access
      Protective effects of (2E)-3-[5-(2,3-dimethoxy-6-methyl-1,4- benzoquinoyl)]-2-nonyl-2-propenoic acid on endotoxin-mediated hepatitis in mice.
      J Nagakawa, I Hishinuma, K Miyamoto, K Hirota, S Abe, T Yamanaka, K Katayama and I Yamatsu
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 145-150;
  3. Yamaoka, M

    1. You have access
      FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
      H Morimoto, M Murai, Y Maeda, M Yamaoka, M Nishikawa, S Kiyotoh and T Fujii
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 398-402;
  4. Yamatsu, I

    1. You have access
      Protective effects of (2E)-3-[5-(2,3-dimethoxy-6-methyl-1,4- benzoquinoyl)]-2-nonyl-2-propenoic acid on endotoxin-mediated hepatitis in mice.
      J Nagakawa, I Hishinuma, K Miyamoto, K Hirota, S Abe, T Yamanaka, K Katayama and I Yamatsu
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 145-150;
  5. Yasuda, H

    1. You have access
      A central nervous system action of nitric oxide in blood pressure regulation.
      H Togashi, I Sakuma, M Yoshioka, T Kobayashi, H Yasuda, A Kitabatake, H Saito, S S Gross and R Levi
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 343-347;
  6. Yoshioka, M

    1. You have access
      A central nervous system action of nitric oxide in blood pressure regulation.
      H Togashi, I Sakuma, M Yoshioka, T Kobayashi, H Yasuda, A Kitabatake, H Saito, S S Gross and R Levi
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 343-347;

Z

  1. Zajac, J M

    1. You have access
      Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine.
      B Frances, R Gout, B Monsarrat, J Cros and J M Zajac
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 25-31;
  2. Zhou, Y

    1. You have access
      Morphine potentiates transforming growth factor-beta release from human peripheral blood mononuclear cell cultures.
      C C Chao, S Hu, T W Molitor, Y Zhou, M P Murtaugh, M Tsang and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 19-24;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 262, Issue 1
1 Jul 1992
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • Stem Cells Therapies in AD
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics